Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor

about

Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat.

P2860

Q47124995-DD1FCEDE-971D-46A8-8A57-F793E74461D1

P2860

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor

Item

http://www.wikidata.org/entity/Q37602780

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor

@en

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.

@nl

type

Item

label

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor

@en

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.

@nl

prefLabel

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor

@en

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.

@nl

P1476

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor

@en

P2093

Jesse Pace

http://www.w3.org/2001/XMLSchema#string

Joy Davis

http://www.w3.org/2001/XMLSchema#string

Mark N Higgins

http://www.w3.org/2001/XMLSchema#string

Minoo Niknian

http://www.w3.org/2001/XMLSchema#string

Sonya L Heltshe

http://www.w3.org/2001/XMLSchema#string

Steven M Rowe

http://www.w3.org/2001/XMLSchema#string

Valerie Tarn

http://www.w3.org/2001/XMLSchema#string

P2860

GH improves growth and clinical status in children with cystic fibrosis -- a review of published studies

Appetite stimulants for people with cystic fibrosis

Recombinant growth hormone therapy for cystic fibrosis in children and young adults

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

The insulin-like growth factor system and nutritional assessment

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.

Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.

Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.

P31

scholarly article

P356

10.1542/PEDS.2016-2522

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Michael Stalvey

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28143919

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

5260152

http://www.w3.org/2001/XMLSchema#string

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor

about

P2860

P2860

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932